You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemo-Radioimmunotherapy

Showing 1 - 25 of 988
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)

Active, not recruiting
  • Mantle Cell Lymphoma
  • R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
  • Basking Ridge, New Jersey
  • +4 more
Dec 1, 2022

Squamous Cell Carcinoma of Larynx Trial in São Paulo (carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v.

Recruiting
  • Squamous Cell Carcinoma of Larynx
  • carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v. on day 1, every 21 days for 3 cycles
  • +2 more
  • São Paulo, Brazil
    Beneficiencia Portuguesa de São Paulo/Hospital São José
Dec 22, 2022

Lymphoma Trial in United Kingdom (biological, drug, radiation)

Terminated
  • Lymphoma
  • rituximab
  • +5 more
  • Manchester, England, United Kingdom
  • +4 more
Dec 16, 2021

Lung Cancer Trial in Switzerland (drug, radiation, procedure)

Completed
  • Lung Cancer
  • Basel, Switzerland
  • +14 more
Mar 10, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +9 more
  • Allogeneic Bone Marrow Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 4, 2021

Ovarian Cancer Trial in Gothenburg (211-astatine MX35 F(ab')2)

Completed
  • Ovarian Cancer
  • 211-astatine MX35 F(ab')2
  • Gothenburg, Sweden
    Sahlgrenska University Hospital, Dept of Oncology
Jul 2, 2020

Non-hodgkin Lymphoma Trial (CD38-SADA:177Lu-DOTA Complex)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • CD38-SADA:177Lu-DOTA Complex
  • (no location specified)
Aug 15, 2023

HNSCC, Head Neck Cancer, Oropharynx Cancer Trial in Groningen (blood draws)

Recruiting
  • HNSCC
  • +4 more
  • blood draws
  • Groningen, Netherlands
    University Medical Center Groningen (UMCG)
Aug 23, 2023

Metastatic Colorectal Cancer Trial in Nantes (Antibody TF2, 90-Y-IMP-288, 111-In-IMP-288)

Terminated
  • Metastatic Colorectal Cancer
  • Antibody TF2
  • +2 more
  • Nantes, France
    CHU de Nantes
Jul 29, 2022

Cancer Patients: Non-invasive Optical Measurements of the Brain

Withdrawn
  • Signs and Symptoms
  • Diffuse optical spectroscopy and Near infrared spectroscopy
  • (no location specified)
Oct 28, 2022

SCCHN, Squamous Cell Carcinoma Trial in Birmingham (Cisplatin)

Recruiting
  • SCCHN
  • Squamous Cell Carcinoma
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 5, 2023

Rectal Cancer Trial (Chemoradiation treatment, 18FDG-PET/MRI scan)

Not yet recruiting
  • Rectal Cancer
  • Chemoradiation treatment
  • 18FDG-PET/MRI scan
  • (no location specified)
Sep 26, 2023

SCLC, Malignant Melanoma, Sarcoma Trial (GD2-SADA:177Lu-DOTA Complex)

Not yet recruiting
  • SCLC
  • +2 more
  • GD2-SADA:177Lu-DOTA Complex
  • (no location specified)
May 4, 2022

Cervical Cancer, Advanced Cancer Trial in Romania, Spain, Turkey (No Further Treatment, TSR-042)

Recruiting
  • Cervical Cancer
  • Advanced Cancer
  • Elche, Alicante, Spain
  • +28 more
Oct 17, 2022

Locally Advanced Cervical Cancer, Gemcitabine, Chemo-radiotherapy Trial in México (Gemcitabine, Cisplatin)

Recruiting
  • Locally Advanced Cervical Cancer
  • +2 more
  • México, Ciudad De México, Mexico
    National Cancer Institute of Mexico
Nov 27, 2023

Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial in Worldwide (drug, biological, radiation)

Recruiting
  • Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • Birmingham, Alabama
  • +187 more
Jan 31, 2023

Medulloblastoma, Childhood Trial in Worldwide (177Lu-DTPA-omburtamab)

Terminated
  • Medulloblastoma, Childhood
  • Rochester, Minnesota
  • +9 more
Aug 15, 2022

NSCLC Trial in Chongqing (procedure, drug, radiation)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • bronchial artery interventional therapy
  • +3 more
  • Chongqing, Chongqing, China
    Daping Hospital, Third Military Medical University
May 27, 2023

Hodgkin Disease, Hodgkin Lymphoma Trial run by the NCI (procedure, drug, radiation)

Terminated
Has Results
  • Hodgkin Disease
  • Hodgkin Lymphoma
  • Auto stem cell transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021

Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant

Not yet recruiting
  • Breast Cancer Triple Negative
  • +3 more
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    May 18, 2023

    Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx Trial in Ann Arbor (procedure, combination product, other,

    Recruiting
    • Oropharyngeal Cancer
    • Squamous Cell Carcinoma of the Oropharynx
    • Surgery
    • +3 more
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    May 30, 2023

    Gastric Cancer, Esophageal Cancer, Stomach Cancer Trial in Saint Louis (CA-4948, 5-FU, Leucovorin)

    Not yet recruiting
    • Gastric Cancer
    • +4 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 27, 2022

    Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemo)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Split-course hypo-CCRT
    • +2 more
    • Guangzhou, Guangdong, China
      Sun yat-sen University Cancer Center
    Aug 26, 2023

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Actinium Ac 225-DOTA-Daratumumab, Daratumumab,

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Actinium Ac 225-DOTA-Daratumumab
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Gallbladder Cancer Unresectable Trial in Lucknow (chemoradiation)

    Recruiting
    • Gallbladder Cancer Unresectable
    • chemoradiation
    • Lucknow, Uttar Pradesh, India
      Sanjay Gandhi Postgraduate Institute of Medical Sciences
    Aug 6, 2022